Fig. 3: Agreement on the use of proposed nomenclature terms for Sjögren.
From: 2023 International Rome consensus for the nomenclature of Sjögren disease
The figure summarizes the results of the second Delphi round, in which Task Force participants and patient representatives were surveyed regarding their support for the usage of each of five nomenclature options. Participants were asked to express their agreement or disagreement with the use of each term on a 1–5 Likert scale, with 1 representing strong disagreement and 5 representing strong agreement; results of the survey are provided in Supplementary Table 2. Overall, a majority of participants supported the use of the term ‘Sjögren disease’.
